Making early-stage investing accessible to all Canadians.
© Copyright 2026 FrontFundr Financial Services Inc. (FFS). All rights reserved. FrontFundr Financial Services Inc. (FFS), doing business as FrontFundr and SMV Capital Markets, is registered as an exempt market dealer in BC, AB, SK, MB, ON, QC, NB, NS, NL, PE & YT. Investing in crowdfunding and exempt market offerings has significant risk. Investors may not be able to resell quickly or at all. An exempt market security holder may also receive limited ongoing issuer information. You should invest only if you are prepared not to receive any return on your investment and/or lose your investment in its entirety.
MONTREAL, June 25, 2024 /PRNewswire/ -- In a significant stride for cancer treatment, Starpax Biopharma Inc. ("Starpax") unveiled its Starpax Cancer Treatment Platform™, a groundbreaking innovation that marks a monumental achievement in the company's journey towards pioneering new frontiers in cancer treatment. With a 100% remission rate and no meaningful side effects in all the subjects of the company's preclinical trials, this technology is conceived to address solid tumors, representing 90% of cancer and 89% of deaths.
To read the complete press release:https://www.prnewswire.com/news-releases/starpax-biopharma-never-before-seen-magnetodrones-and-polartrak-technology-transform-cancer-treatment-302181096.html
